AI SummaryIndia's obesity drug market is projected to grow from ₹1,500 cr to ₹8,000 cr by 2030, creating a parallel opportunity for complementary protein-rich functional foods. Major dairy companies like Amul have publicly identified protein as an underserved growth vertical, signaling clear manufacturing and distribution readiness. A startup manufacturing research-backed, high-protein products (yogurts, flour blends, cheese) and distributing via pharma clinics, online pharmacies, and FMCG channels can capture 2-5% market share (₹160-400 cr) by 2030. This is ideal for food technologists, nutritionists, and FMCG entrepreneurs with access to contract manufacturing and clinical validation networks.
Loading...